ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1390	National Cancer Institute	Html	en	Parathyroid Cancer Treatment (PDQ®)–Health Professional Version	Parathyroid cancer is very rare and is usually treated with surgery. Learn about the diagnosis, risk and genetic factors, staging, treatment, and management of parathyroid cancer in this expert-reviewed summary.	En bloc excision 0.580723 malignant parathyroid tumors 0.70882 benign parathyroid disease 0.742032 useful imaging adjuncts 0.564425 parathyroid cancer. 0.73642 Cervical lymph node 0.577512 Cancer Database series 0.580761 important new approach 0.566545 small tumor deposits 0.584869 parathyroid adenomas 0.693339 primary HPT 0.572268 parathyroid hormone 0.692017 patients 0.614406 frequent presenting complaint 0.563224 parathyroid carcinoma 0.974986 serum PTH concentrations 0.583231 trabecular growth patterns 0.562685 parathyroid cancer 0.749285 lymph nodes 0.628841 histologic cell types 0.567408 fewer patients 0.586809 Accessible distant metastases 0.572395 Serum PTH levels 0.584551 bloc resection 0.588765 overt skeletal involvement 0.564555	fairly indolent biology 0.562712 parathyroid adenoma 0.751441 low malignant potential 0.583743 parathyroid cancers 0.811741 local recurrence rate. 0.578566 adjuvant radiation therapy 0.564112 parathyroid carcinoma. 0.775435 recurrent laryngeal nerve 0.652868 hyperparathyroid bone disease 0.578044 parathyroid procedures 0.706298 cervical lymph nodes 0.58395 malignant tumor 0.574608 malignant parathyroid lesions. 0.713559 long-term local control 0.567886 dense fibrous trabeculae 0.563413 difficult-to-detect recurrent disease. 0.574206 parathyroid adenomas. 0.68234 primary tumor 0.565018 initial treatment goal 0.574628 median maximal diameter 0.575198 inferior parathyroid glands 0.778319 regional lymph nodes 0.602965 mixed cell types 0.564125 lymph node metastases 0.599404	CLICK HERE
1552	National Cancer Institute	Html	en	Childhood Acute Lymphoblastic Leukemia Treatment (PDQ®)–Patient Version	Childhood ALL is a type of cancer in which the bone marrow makes too many immature lymphocytes (a type of white blood cell). Here’s what you need to know about the risk factors, signs, tests to diagnose, and treatment of newly diagnosed and recurrent ALL in this expert-reviewed summary.	red blood cells 0.416225 cancer treatment 0.28631 chemotherapy 0.431874 treatments 0.247489 PDQ cancer information 0.278302 clinical trial search 0.311111 white blood cells 0.50903 children 0.34365 systemic chemotherapy 0.367092 higher doses 0.258659 mature blood cells 0.277223 Natural killer cells 0.232346 cancer information summary 0.242631 clinical trial 0.414978 stem cells 0.325781 stem cell transplant 0.490178 Lymphoblastic Leukemia Treatment 0.242048 blood cells 0.556083 intrathecal chemotherapy 0.289545 radiation therapy 0.442509 General information 0.218828 child 0.225345 treatment 0.73359 immature blood cells 0.228445 NCI-supported cancer 0.228604	cancer cells 0.364563 remission induction 0.378898 anticancer drugs 0.454791 specific cancer cells 0.244448 acute lymphocytic leukemia 0.228943 certain changes 0.25566 treatment clinical trials 0.245143 blood stem cells 0.262182 National Cancer Institute 0.245665 spinal cord 0.639894 ) cells. 0.915202 new treatment 0.267478 consolidation /intensification 0.293759 childhood 0.307766 clinical trials 0.932686 combination chemotherapy 0.358378 maintenance phases 0.246634 brain 0.275475 bone marrow 0.619374 Philadelphia chromosome 0.248781 cancer clinical trials 0.319159 acute lymphoblastic leukemia 0.930995 cancer 0.710977 information 0.309067	CLICK HERE
1714	National Cancer Institute	Html	en	Computed Tomography (CT) Scans and Cancer	A fact sheet that describes the CT scan procedure and technology and its uses in screening, diagnosis, and treatment.	CT imaging technology 0.569562 regular-dose CT scan 0.562007 lung cancer screening 0.54026 CT procedure 0.731231 newest CT scanners 0.587346 whole-body CT 0.57001 ct exams 0.558916 CT procedures 0.54984 lung cancer 0.592986 radiation dose 0.50377 health care providers 0.544231 multislice CT 0.569592 U.S. Food 0.504864 Lung Screening Trial 0.488364 single CT scan 0.559043 ct colonography 0.665422 colorectal cancer 0.498955 older CT techniques 0.588973 Tracking radiation exposure 0.48666 multiple CT scans 0.560065 standard CT 0.559346 National CT Colonography 0.621292 helical CT procedure 0.596247 low-dose CT scan 0.568401	average annual dose 0.483921 CT scanner manufacturers 0.553452 CT scans 0.582194 low-dose helical CT 0.69526 radiation risks 0.502098 Drug Administration 0.507156 radiation exposure 0.603574 modern CT machines 0.590707 American College 0.525134 original CT machines 0.590542 CT imaging 0.587843 National Lung Screening 0.489052 external-beam radiation therapy 0.487398 people 0.506505 natural background radiation 0.502791 CT 0.922359 radiation dose exposures 0.484749 radiation 0.608408 Unnecessary Radiation Exposure 0.486946 cancer risk 0.502536 cancer 0.609695 CT scanners 0.63294 multidetector CT scanners 0.588732 typical CT procedure 0.581742	CLICK HERE
1780	National Cancer Institute	Html	es	Tensión postraumática relacionada con el cáncer (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca de la tensión postraumática y síntomas relacionados en los pacientes con cáncer, sobrevivientes del cáncer y miembros de la familia. Se discuten la evaluación y tratamiento de estos síntomas.	Coping with 0.312113 symptoms after 0.319304 Traumatic Stress Studies 0.314051 MOPP alternating with 0.310501 Trauma Stress 0.351142 Nerv Ment Dis 0.328654 Cella DF 0.451191 Arch Gen Psychiatry 0.346852 Leukemia Group B 0.316545 Post-traumatic stress after 0.328039 stress after childhood 0.327952 alternating with abvd 0.310501 Jacobsen PB 0.352264 Acute stress 0.312113 patients following autologous 0.318583 among holocaust survivors 0.314603 combat-related posttraumatic stress 0.348262 mental disorders 0.366349 criterio diagnóstico 0.338544 Green BL 0.343463 Human Stress 0.337499 traumatic stress symptoms 0.314194 cooperative clinical trials 0.320094 Hosp Community Psychiatry 0.312333 childhood cancer 0.324585	síntomas específicos tpt 0.311452 Widows MR 0.315755 tensión postraumática ttpt 0.310392 Grace MC 0.31562 Structured Clinical Interview 0.330114 postdisaster psychiatric disorders 0.311579 American Psychiatric Association 0.427992 bone marrow transplantation 0.440615 Cordova MJ 0.331735 posttraumatic stress 0.9934 Consult Clin Psychol 0.37836 life assessment 0.310879 Lindy JD 0.315479 marrow transplant recipients 0.310103 Event Scale 0.315869 Abnorm Psychol 0.310829 Kornblith AB 0.369198 Statistical Manual 0.340058 symptoms after treatment 0.312687 Anderson J 0.350583 stress symptoms 0.322303 Andrykowski MA 0.321927 post-traumatic stress 0.369384 after burn 0.311819	CLICK HERE
1963	National Cancer Institute	Html	es	Tratamiento del carcinoma de células de Merkel (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del carcinoma de células de Merkel.	siguientes procedimientos 0.69003 estadio iv 0.713668 siguientes aspectos 0.637912 ganglio linfático centinela 0.981847 vía oral 0.618977 rayos x 0.627438 estadio ib 0.770198 Merkel causa efectos 0.682552 estadio ia 0.76846 escáner tep 0.628975 luz solar 0.628063 National Cancer Institute 0.617139 siguientes riesgos 0.613115	ganglios linfáticos.ampliar biopsia 0.728335 nota cambios 0.628407 Instituto Nacional 0.631866 estadio iiia 0.644166 PDQ Tratamiento 0.631004 estadio iia 0.644928 estadio iic 0.644457 Physician Data Query 0.665687 último panel 0.626069 siguientes características 0.637587 siguientes pruebas 0.688976 radiación ultravioleta 0.629465 siguientes estadios 0.630948	CLICK HERE
1976	National Cancer Institute	Html	es	Tratamiento del cáncer de seno paranasal y de cavidad nasal (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de seno paranasal y de cavidad nasal.	glándula tiroides 0.30201 Neck Cancer 0.300319 siguientes procedimientos 0.303848 pequeño número 0.300609 siguientes aspectos 0.300986 estadio ii 0.30355 senos paranasales esfenoideos 0.304208 siguientes especialistas 0.300629 aire circula 0.300623 rayos x 0.300535 pequeñas marcas 0.300312 estadio ivc 0.301666 enlace drugs approved 0.300597 seno paranasal 0.995188 dientes flojos 0.300615 nasal envía señales 0.304954	dentaduras postizas 0.300692 National Cancer Institute 0.300148 tumores benignos 0.300663 siguientes riesgos 0.300156 fraccionamiento.ampliar radioterapia 0.301581 Instituto Nacional 0.300695 malla ayuda 0.300318 PDQ Tratamiento 0.300448 Physician Data Query 0.300682 siguientes sitios 0.301656 ganglio linfático mide 0.30303 aparato respiratorio ayuda 0.301084 siguientes enlaces 0.300254 senos paranasales etmoideos 0.307274 siguientes pruebas 0.30092	CLICK HERE
2040	National Cancer Institute	Html	es	Exámenes de detección del cáncer de piel (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca de las pruebas que se utilizan para detectar sistemáticamente el cáncer de piel.	antecedentes familiares 0.452736 nevo atípico 0.361408 almacena agua 0.367337 lámparas solares 0.360685 PDQ Exámenes 0.39849 Physician Data Query 0.505569 mayores probabilidades 0.363001 radiación uv 0.621972 Estados Unidos 0.932757 simple vista 0.348992 prevención revisa 0.335498 Skin Cancer 0.36265	siguientes ejemplos 0.362131 luz solar 0.675106 información ayuda 0.338156 vitamina d 0.367339 Características genéticas 0.361581 National Cancer Institute 0.353374 siguientes riesgos 0.336165 piel melanoma 0.814223 radiación ultravioleta 0.507855 siguientes sumarios 0.40536 Instituto Nacional 0.399902	CLICK HERE
3416	National Cancer Institute	Html	en	The NCTN Budget	The overall NCTN budget for these awards is $151 million. This amount is the same as the total budget provided to the Cooperative Groups for awards in each of fiscal years 2012 and 2013, despite the substantial reductions in the NCI budget that resulted from sequestration starting in 2013. What has changed, however, is the distribution of funds to the various components of the NCTN, as compared with the components of the former Cooperative Group program.	future clinical trials 0.56818 large numbers 0.48775 medicine clinical trials 0.552592 Medidata Rave® 0.477945 smaller interventional components 0.50085 NCI budget 0.524673 complex analytic algorithms 0.469817 important trials 0.467438 clinical trial functions 0.476947 additional annual support 0.477353 entail new expenses 0.505576 clinical trials 0.953052 funding supplements 0.459855 one-stop online access 0.458554 Group Operations Center 0.520009 normal genetic variants 0.470288 overall NCTN budget 0.558633 patients 0.498402 separate funding stream 0.466002 Network Group Operations 0.667965 Investigational New Drug 0.483971 NCTN treatment trials 0.641251 fresh biopsy samples 0.473644 Studies Funding Program 0.482252 Group Operations Centers 0.508084	NCI 0.653194 patient selection 0.483879 U.S. adult groups 0.497468 appropriate molecular profile 0.474342 Cooperative Groups 0.505409 RNA sequencing methods 0.473512 Cancer Trials Support 0.534613 NCTN trials 0.601972 actual interventional study 0.491932 specific molecular characteristics 0.475625 fewer active trials 0.544364 rapid turnaround times 0.471955 NCTN groups 0.757227 NCTN Group Operations 0.525903 separate NCI award 0.549229 interventional trials 0.493629 newly consolidated groups 0.490605 Cooperative Group program 0.522132 larger therapeutic effects 0.463659 correlative science studies 0.465254 common data management 0.623125 new trials 0.510263 group trials 0.461981 previous trials 0.464198	CLICK HERE
3854	National Cancer Institute	Html	en	With Immunotherapy, Glimmers of Progress against Glioblastoma	Researchers who specialize in brain cancer are optimistic about immunotherapy’s prospects for improving outcomes in patients with this aggressive form of brain cancer.	small trial testing 0.468005 Dr. Gilbert 0.515178 tumor-specific immune response 0.48073 malignant brain tumor 0.510587 early-phase trial testing 0.467191 dendritic cells 0.61475 operable glioblastoma 0.578819 specialized endothelial cells 0.558383 dendritic cell vaccines 0.48246 clinical trials 0.590613 glioblastoma cells 0.815515 12-patient clinical trial 0.463613 so-called peptide vaccine 0.471528 immature immune cells 0.5807 patients 0.746073 brain cancer 0.489359 healthy brain cells 0.678016 immune-based treatments 0.561628 CAR T-cell therapy 0.537367 glioblastoma 0.965748 brain tumor immunotherapy 0.646246 contractile cells 0.490726 EGFRvIII-positive glioblastoma 0.583166 checkpoint inhibitors 0.623905 glioblastoma patients 0.63769	CAR T cells 0.567214 Dr. Sampson 0.590733 advanced glioblastoma 0.567342 delivery cancer treatments 0.470619 trial testing 0.590548 immune response 0.549878 Dr. Lim 0.552388 tumor cells 0.483775 small randomized trial 0.471443 advanced melanoma 0.473209 immune cells 0.646076 trial testing rindopepimut 0.489783 Comprehensive Cancer Center 0.46874 CMV-infected cells 0.470459 newly diagnosed glioblastoma 0.754821 early-stage clinical trials 0.589931 engineering cells 0.471397 tumor immunotherapy program 0.633115 cells 0.839043 dendritic cell vaccine 0.705918 phase I/II trial 0.478298 larger randomized trials 0.595338 cancer 0.501031 glioblastoma tumors 0.562465	CLICK HERE
17193	National Cancer Institute	Html	en	U.S. - China Program for Biomedical Research Cooperation	U.S. - China Program for Biomedical Research Cooperation Preliminary Program Review.	Office 0.440565 OAR 0.472714 Allergy 0.446266 scientific accomplishments 0.62865 projects 0.51324 Additional outcomes 0.632018 National Natural Science 0.9169 Mental Health 0.663295 Chinese scientists 0.664312 translational biomedical research. 0.976759 National Cancer Institute 0.919012 Foundation 0.442112 preliminary evaluation 0.675445 US-China 0.436834 results 0.435543 National Institute 0.932171 National Institutes 0.697264 common successes 0.636736 Administrative Supplements 0.654736 Stroke 0.440417 Collaborative Biomedical Research 0.935063	Global Health 0.637782 NSFC 0.441999 future collaborative programs 0.854353 impacts 0.442029 countries 0.439905 NIAID 0.482086 NIH 0.458074 international collaboration 0.640713 joint initiative 0.663479 Neurological Disorders 0.660677 NIMH 0.468305 Researchers 0.441544 U.S.-China Program 0.677605 report 0.435896 Infectious Diseases 0.665033 scientifically meritorious investigations 0.921915 Biomedical Research Cooperation 0.865108 Preliminary Program Review 0.859879 AIDS Research 0.660227 R01 mechanisms 0.711872	CLICK HERE